September 2020 Vol 13, No 4

Editorial

The Idealism of Youth

David B. Nash, MD, MBA

Business, Original Research

Analysis of Stakeholder Engagement in the Public Comments of ICER Draft Evidence Reports

Jean A. Gerlach; Brian Snow, PharmD; Katherine M. Prioli, MS; Ronald Vertsman, PharmD; Julie Patterson, PharmD, PhD; Laura T. Pizzi, PharmD, MPH

Business, Original Research

Knee Osteoarthritis Treatment Costs in the Medicare Patient Population

Gerard Malanga, MD; Faizan Niazi, PharmD; Vasco Deon Kidd, DHSc, MPH, MS, PA-C; Edmund Lau, MS; Steven M. Kurtz, PhD; Kevin L. Ong, PhD, PE; Andrew L. Concoff, MD, FACR, CAQSM

Clinical, Original Research

Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs for Patients with Newly Diagnosed Systolic versus Diastolic Heart Failure

Chi Nguyen, PhD; Xian Zhang, PhD; Thomas Evers, PhD; Vincent J. Willey, PharmD; Hiangkiat Tan, MS, BPharm; Thomas P. Power, MD, FACC, MRCPI

COVID-19, Perspectives

Are Nursing Homes COVID-19’s “Contaminated Wells,” and Will They Receive Additional Resources?

Bruce Pyenson, FSA, MAAA, and David C. Grabowski, PhD

COVID-19, Perspectives

90 Days in 2020: COVID-19 Exposes Health Equity Opportunities

Byron C. Scott, MD, MBA

Results 1 - 6 of 6